BIOMAT Database Logo BIOMAT Database Logo

Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo. 1994

M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Department of Clinical Pharmacology, Vienna University Hospital, Allgemeines Krankenhaus, Austria.

The direct and noradrenaline-modulating effects of neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) on venous smooth muscle were studied in healthy volunteers employing the dorsal hand vein compliance technique. Local infusions of NPY had no measurable effect on venous tone, but coinfusion of a constant high dose of NPY (242 pmol/min) with noradrenaline caused a 2.9-fold increase in the mean ED50 for noradrenaline. The dilating effect of VIP on preconstricted hand veins was weak, maximal venodilation could not be achieved, because systemic side effects occurred at submaximally venodilating doses. Coinfusion of noradrenaline with a weakly venodilating, constant dose of VIP (93.2 pmol/min) caused a 0.5-fold decrease in the sensitivity for noradrenaline. Although functional interactions between NPY or VIP and noradrenaline could be demonstrated, the dosages of the peptides required were high. Thus our results indicate that neither NPY nor VIP exert a major direct or noradrenaline-modulating effect on human veins.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal
D014680 Veins The vessels carrying blood away from the CAPILLARY BEDS. Vein

Related Publications

M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Effects of vasoactive intestinal peptide, peptide histidine methionine, and neuropeptide Y on intracavernous pressure in the rabbit.
September 1992, Urology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Release of vasoactive intestinal peptide and neuropeptide Y from canine heart.
September 1993, The American journal of physiology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Immunocytochemical localization of vasoactive intestinal peptide and neuropeptide Y in the bovine ovary.
March 1994, Biology of reproduction,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Effects of neuropeptide Y (NPY), galanin and vasoactive intestinal peptide (VIP) on pituitary hormone release and on ovarian steroidogenesis.
January 1999, Neuro endocrinology letters,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries.
October 1986, Annals of neurology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Effects of avian pancreatic peptide on smooth muscle relaxations by vasoactive intestinal peptide and inhibitory nerve stimulation.
March 1986, Japanese journal of pharmacology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach.
March 1991, British journal of pharmacology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Chemotactic activities of vasoactive intestinal peptide, neuropeptide Y and substance P in Leishmania braziliensis.
December 2020, Experimental parasitology,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers.
January 1994, Circulation research,
M Wolzt, and W Gerschlager, and B Zweytick, and B Jilma, and H Riemer, and K Sertl, and H G Eichler
The vasoactive effects of bradykinin, vasoactive intestinal peptide, calcitonin gene-related peptide and neuropeptide Y depend on the perivascular tissue in porcine retinal arterioles in vitro.
May 2024, Acta ophthalmologica,
Copied contents to your clipboard!